View of A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY

Return to Article Details A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY Download Download PDF